OUT OF MIND
Would you like to react to this message? Create an account in a few clicks or log in to continue.
Latest topics
» Is it possible to apply positive + in favor Newton III Motion Law as a dynamic system in a motor engine
Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection EmptySat Mar 23, 2024 11:33 pm by globalturbo

» Meta 1 Coin Scam Update - Robert Dunlop Arrested
Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection EmptySat Mar 23, 2024 12:14 am by RamblerNash

» As We Navigate Debs Passing
Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection EmptyMon Jan 08, 2024 6:18 pm by Ponee

» 10/7 — Much More Dangerous & Diabolical Than Anyone Knows
Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection EmptyThu Nov 02, 2023 8:30 pm by KennyL

» Sundays and Deb.....
Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection EmptySun Oct 01, 2023 9:11 pm by NanneeRose

» African Official Exposes Bill Gates’ Depopulation Agenda: ‘My Country Is Not Your Laboratory’
Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection EmptyThu Sep 21, 2023 4:39 am by NanneeRose

» DEBS HEALTH
Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection EmptySun Sep 03, 2023 10:23 am by ANENRO

» Attorney Reveals the “Exculpatory” Evidence Jack Smith Possesses that Exonerates President Trump
Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection EmptyTue Aug 29, 2023 10:48 am by ANENRO

» Update From Site Owner to Members & Guests
Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection EmptyTue Aug 29, 2023 10:47 am by ANENRO

» New global internet censorship began today
Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection EmptyMon Aug 21, 2023 9:25 am by NanneeRose

» Alienated from reality
Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection EmptyMon Aug 07, 2023 4:29 pm by PurpleSkyz

» Why does Russia now believe that Covid-19 was a US-created bioweapon?
Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection EmptyMon Aug 07, 2023 4:27 pm by PurpleSkyz

»  Man reports history of interaction with seemingly intelligent orbs
Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection EmptyMon Aug 07, 2023 3:34 pm by PurpleSkyz

» Western reactions to the controversial Benin Bronzes
Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection EmptyMon Aug 07, 2023 3:29 pm by PurpleSkyz

» India unveils first images from Moon mission
Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection EmptyMon Aug 07, 2023 3:27 pm by PurpleSkyz

» Scientists achieve nuclear fusion net energy gain for second time
Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection EmptyMon Aug 07, 2023 3:25 pm by PurpleSkyz

» Putin Signals 5G Ban
Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection EmptyMon Aug 07, 2023 3:07 pm by PurpleSkyz

» “Texas Student Dies in Car Accident — Discovers Life after Death”
Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection EmptyMon Aug 07, 2023 3:05 pm by PurpleSkyz

» The hidden history taught by secret societies
Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection EmptyMon Aug 07, 2023 3:03 pm by PurpleSkyz

» Vaccines and SIDS (Crib Death)
Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection EmptyMon Aug 07, 2023 3:00 pm by PurpleSkyz

» Sun blasts out highest-energy radiation ever recorded, raising questions for solar physics
Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection EmptyMon Aug 07, 2023 2:29 pm by PurpleSkyz

» Why you should be eating more porcini mushrooms
Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection EmptySun Aug 06, 2023 10:38 am by PurpleSkyz


You are not connected. Please login or register

Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection

Go down  Message [Page 1 of 1]

PurpleSkyz

PurpleSkyz
Admin

Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection



  • Rh Negative Facts

 Mike Dammann
October 21, 20200

Thank you very much to those of you who have brought this article to my attention. I have earlier posted a study highlighted in it. Please use the comment section for questions and bringing up whatever is of interest.
The original article can be viewed here.
Here it is:
Johns Hopkins Researchers Identify Immune System Pathway That May Stop COVID-19 Infection SARS-COV-2-Virus-Particles-on-Cell-777x668

Colorized scanning electron micrograph of a cell (purple) heavily infected with SARS-CoV-2 virus particles (yellow). A recent study by Johns Hopkins Medicine shows that blocking a specific protein in a biological pathway may prevent SARS-CoV-2 infection and keep the virus from misdirecting the immune system against healthy cells and organs. Credit: National Institute of Allergy and Infectious Diseases, National Institutes of Health


Blocking Immune System Pathway May Stop COVID-19 Infection, Prevent Severe Organ Damage
While the world waits eagerly for a safe and effective vaccine to prevent infections from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus behind the COVID-19 pandemic, researchers also are focusing on better understanding how SARS-CoV-2 attacks the body in the search for other means of stopping its devastating impact. The key to one possibility — blocking a protein that enables the virus to turn the immune system against healthy cells — has been identified in a recent study by a team of Johns Hopkins Medicine researchers.

Based on their findings, the researchers believe that inhibiting the protein, known as factor D, also will curtail the potentially deadly inflammatory reactions that many patients have to the virus.
Making the discovery even more exciting is that there may already be drugs in development and testing for other diseases that can do the required blocking.
The study was published recently in the journal Blood.
Scientists already know that spike proteins on the surface of the SARS-CoV-2 virus — making the pathogen look like the spiny ball from a medieval mace — are the means by which it attaches to cells targeted for infection. To do this, the spikes first grab hold of heparan sulfate, a large, complex sugar molecule found on the surface of cells in the lungs, blood vessels and smooth muscle making up most organs. Facilitated by its initial binding with heparan sulfate, SARS-CoV-2 then uses another cell-surface component, the protein known as angiotensin-converting enzyme 2 (ACE2), as its doorway into the attacked cell.

The Johns Hopkins Medicine team discovered that when SARS-CoV-2 ties up heparan sulfate, it prevents factor H from using the sugar molecule to bind with cells. Factor H’s normal function is to regulate the chemical signals that trigger inflammation and keep the immune system from harming healthy cells. Without this protection, cells in the lungs, heart, kidneys and other organs can be destroyed by the defense mechanism nature intended to safeguard them.
“Previous research has suggested that along with tying up heparan sulfate, SARS-CoV-2 activates a cascading series of biological reactions — what we call the alternative pathway of complement, or APC — that can lead to inflammation and cell destruction if misdirected by the immune system at healthy organs,” says study senior author Robert Brodsky, M.D., director of the hematology division at the Johns Hopkins University School of Medicine. “The goal of our study was to discover how the virus activates this pathway and to find a way to inhibit it before the damage happens.”
The APC is one of three chain reaction processes involving the splitting and combining of more than 20 different proteins — known as complement proteins — that usually gets activated when bacteria or viruses invade the body. The end product of this complement cascade, a structure called membrane attack complex (MAC), forms on the surface of the invader and causes its destruction, either by creating holes in bacterial membranes or disrupting a virus’ outer envelope. However, MACs also can arise on the membranes of healthy cells. Fortunately, humans have a number of complement proteins, including factor H, that regulate the APC, keep it in check and therefore, protect normal cells from damage by MACs.

In a series of experiments, Brodsky and his colleagues used normal human blood serum and three subunits of the SARS-CoV-2 spike protein to discover exactly how the virus activates the APC, hijacks the immune system and endangers normal cells. They discovered that two of the subunits, called S1 and S2, are the components that bind the virus to heparan sulfate — setting off the APC cascade and blocking factor H from connecting with the sugar — and in turn, disabling the complement regulation by which factor H deters a misdirected immune response.
In turn, the researchers say, the resulting immune system response to chemicals released by the lysing of killed cells could be responsible for the organ damage and failures seen in severe cases of COVID-19.
Most notably, Brodsky says, the research team found by blocking another complement protein, known as factor D, which works immediately upstream in the pathway from factor H, they were able to stop the destructive chain of events triggered by SARS-CoV-2.
“When we added a small molecule that inhibits the function of factor D, the APC wasn’t activated by the virus spike proteins,” Brodsky says. “We believe that when the SARS-CoV-2 spike proteins bind to heparan sulfate, it triggers an increase in the complement-mediated killing of normal cells because factor H, a key regulator of the APC, can’t do its job.”

To better understand what happens, Brodsky says think of the APC like a car in motion.

“If the brakes are disabled, the gas pedal can be floored without restraint, very likely leading to a crash and destruction,” he explains. “The viral spike proteins disable the biological brakes, factor H, enabling the gas pedal, factor D, to accelerate the immune system and cause cell, tissue and organ devastation. Inhibit factor D, and the brakes can be reapplied and the immune system reset.”
Brodsky adds that cell death and organ damage from a misdirected APC associated with factor H suppression is already known to occur in several complement-related human diseases, including age-related macular degeneration, a leading cause of vision loss for people age 50 and older; and atypical hemolytic uremic syndrome (aHUS), a rare disease that causes clots to block blood flow to the kidneys.
Brodsky and his colleagues hope that their work will encourage more study into the potential use against COVID-19 of complement-inhibiting drugs already in the pipeline for other diseases.
“There are a number of these drugs that will be FDA-approved and in clinical practice within the next two years,” Brodsky says. “Perhaps one or more of these could be teamed with vaccines to help control the spread of COVID-19 and avoid future viral pandemics.”
Reference: “Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition” by Jia Yu, Xuan Yuan, Hang Chen, Shruti Chaturvedi, Evan M. Braunstein and Robert A. Brodsky, 2 September 2020, Blood.
DOI: 10.1182/blood.2020008248
Along with Brodsky, the other members of the Johns Hopkins Medicine research team are lead author Jia Yu; Xuan Yuan; Hang Chen; Shruti Chaturvedi, M.B.B.S.; and Evan Braunstein, M.D., Ph.D.
The study was supported by National Heart, Lung and Blood Institute grant R01 HL133113.
Disclaimer: Johns Hopkins Medicine researchers are working tirelessly to find ways to better understand and eventually eliminate COVID-19 and the virus that causes it. Discoveries like this one, especially those related to clinical therapies and drug regimens, are still early in concept and small in sample size. This will require rigorous research, testing and peer review, all of which take time, before solid conclusions for clinical care and disease prevention can be made.

https://www.rhesusnegative.net/staynegative/johns-hopkins-researchers-identify-immune-system-pathway-that-may-stop-covid-19-infection/

Thanks to Mike at: https://www.rhesusnegative.net

Back to top  Message [Page 1 of 1]

Permissions in this forum:
You cannot reply to topics in this forum